Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Deoxyglucose  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Juraschek SP, Steffes MW, Miller ER. "Alternative markers of hyperglycemia and risk of diabetes." Diabetes Care. 2012;35(11):2265-70.
Selvin E, Rawlings A, Lutsey PL, Maruthur N, Pankow JS, Steffes M. "Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality." Diabetes. 2016;65(1):201-8.
Selvin E, Rawlings AM, Grams M, Klein R, Steffes M. "Association of 1,5-anhydroglucitol with diabetes and microvascular conditions." Clin Chem. 2014;60(11):1409-18.
Liang M, McEvoy JWilliam, Chen Y, Sharrett ARichey. "Association of a Biomarker of Glucose Peaks, 1,5-Anhydroglucitol, With Subclinical Cardiovascular Disease." Diabetes Care. 2016;39(10):1752-9.
R
Parrinello CM, Sharrett ARichey, Maruthur NM, Bergenstal RM, Grams ME, Coresh JJ. "Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia." Diabetes Care. 2016;39(4):589-95.
Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL. "Racial differences in glycemic markers: a cross-sectional analysis of community-based data." Ann Intern Med. 2011;154(5):303-9.
Loomis SJ, Köttgen A, Li M, et al. "Rare variants in SLC5A10 are associated with serum 1,5-anhydroglucitol (1,5-AG) in the Atherosclerosis Risk in Communities (ARIC) Study." Sci Rep. 2019;9(1):5941.
S
Rebholz CM, Grams ME, Chen Y, Gross AL, Sang Y, Coresh JJ. "Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease." Am J Epidemiol. 2017;186(8):952-960.
Yu B, Zheng Y, Nettleton JA, Alexander D, Coresh JJ. "Serum metabolomic profiling and incident CKD among African Americans." Clin J Am Soc Nephrol. 2014;9(8):1410-7.